Merck to Use Roche's p53 AmpliChip for Cancer Research | GenomeWeb

This story has been updated to include comments from Roche.

By Justin Petrone

Merck will use Roche's microarray-based AmpliChip p53 test for research purposes, Roche Molecular Systems said last week.

The collaboration is the first time Roche will make the AmpliChip p53 test available to an external partner, according to a Roche spokesperson. The company has used the assay internally in its own research programs, the spokesperson told BioArray News this week.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.

Clinicians look to fold non-medical data into algorithms to predict patients' health, the Wall Street Journal reports.

Connecticut's biotech investment is leading to the building of labs to house new startups, the Associated Press reports.

Craig Venter's Health Nucleus aims to change preventive medicine, according to the Robb Report.